| Literature DB >> 32973339 |
Yahan Wu1,2,3, Liping Zhou1,2,3, Hongyu Liu1,2,3, Ran Duan1,2,3, Huixing Zhou1,2,3, Fulei Zhang1,2,3, Xiaoyu He1,2,3, Dongbo Lu2,4, Ke Xiong1,2,3, Maolin Xiong2,4, Jinzhu Zhuang2,4, Yi Liu1,2, Li Li1,2,3,5,6, Dandan Liang7,8,9,10, Yi-Han Chen11,12,13,14,15.
Abstract
The adult mammalian heart is thought to be a terminally differentiated organ given the postmitotic nature of cardiomyocytes. Consequently, the potential for cardiac repair through cardiomyocyte proliferation is extremely limited. Low-density lipoprotein receptor-related protein 6 (LRP6) is a Wnt co-receptor that is required for embryonic heart development. In this study we investigated the role of LRP6 in heart repair through regulation of cardiomyocyte proliferation. Lrp6 deficiency increased cardiomyocyte cell cycle activity in neonatal, juvenile and adult mice. Cardiomyocyte-specific deletion of Lrp6 in the mouse heart induced a robust regenerative response after myocardial infarction (MI), led to reduced MI area and improvement in left ventricular systolic function. In vivo genetic lineage tracing revealed that the newly formed cardiomyocytes in Lrp6-deficient mouse hearts after MI were mainly derived from resident cardiomyocytes. Furthermore, we found that the pro-proliferative effect of Lrp6 deficiency was mediated by the ING5/P21 signaling pathway. Gene therapy using the adeno-associated virus (AAV)9 miRNAi-Lrp6 construct promoted the repair of heart injury in mice. Lrp6 deficiency also induced the proliferation of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). Our study identifies LRP6 as a critical regulator of cardiomyocyte proliferation, which may lead to the development of a novel molecular strategy to promote myocardial regeneration and repair.Entities:
Mesh：
Substances：
Year: 2020 PMID： 32973339 PMCID： PMC8114926 DOI： 10.1038/s41422-020-00411-7
Source DB: PubMed Journal: Cell Res ISSN： 1001-0602 Impact factor: 25.617